Association of hydroxychloroquine and cardiac arrhythmia in patients with systemic lupus erythematosus: A population-based case control study.
Chien-Hsien LoYu-Hsun WangChin-Feng TsaiKuei-Chuan ChanLi-Ching LiTse-Hsien LoJames Cheng-Chung WeiChun-Hung SuPublished in: PloS one (2021)
In patients with systemic lupus erythematosus, hydroxychloroquine treatment did not significantly increase the risk of cardiac arrhythmia or life-threatening ventricular arrhythmia regardless of the different hydroxychloroquine treatment duration, drug adherence rate, or daily dose.